GLOBAL NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

GLOBAL NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

The global nasal spray devices market is anticipated to generate revenue of $24,264 million and to grow at a CAGR of 6.78% between 2019 and 2027. Global nasal spray devices market deals with the adoption of such devices that are used to deliver drugs through the nose. The following factors primarily drive the nasal spray devices market:

GLOBAL NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

Global Nasal Spray Devices Market by Product (Decongestion Nasal Spray, Saltwater Solution/ Saline Nasal Spray, Steroid Nasal Spray) by Prescription (Over-the-counter, Prescribed) by Therapeutic (Antihistamine, Anticholinergic, Mast Cell Inhibitor, Nasal Steroids) by Application (Allergic and Non-allergic Rhinitis, Cns Disorders, Nasal Congestion, Vaccination, Other Application) by End-user (Asc/clinics, Home Care Setting, Hospital, Pharmacy, Other End-user) by Geography.

Request free sample

The global nasal spray devices market is anticipated to generate revenue of $24,264 million and to grow at a CAGR of 6.78% between 2019 and 2027. Global nasal spray devices market deals with the adoption of such devices that are used to deliver drugs through the nose. The following factors primarily drive the nasal spray devices market:

  • The surge in the incidence of respiratory diseases
  • Low cost of generic prescription drugs

The important drivers increasing growth in the global nasal spray devices market are a surge in the incidence of respiratory diseases and the low cost of generic prescription drugs. The prevalence of chronic obstructive pulmonary diseases (COPD) among respiratory disease can be observed by the growing number of patients with breathing difficulties. The rising adoption of generics drugs due to their lower prescription costs is a major factor influencing the market growth.

The applications and products of nasal spray devices market are used extensively for various purposes. Allergic and non-allergic rhinitis market deals with the adoption of nasal spray devices to treat patients with respective type of rhinitis. CNS disorders market deals with the adoption of nasal spray devices to treat patients with the symptoms of diseases associated with the central nervous system.

The nasal route for vaccination offers some crucial opportunities majorly for the prophylaxis of respiratory diseases. The adoption of technologically advanced nasal sprays including decongestion nasal spray offers patients with greater convenience, which is augmenting the market growth. Saline nasal sprays are considered to be an effective and safe option to get long-term relief from the symptoms of chronic sinusitis and allergic rhinitis. Steroid nasal spray (corticosteroid nasal sprays) market deals with the adoption of such nasal sprays with anti-inflammatory medicines.

The stringent regulations and rising incidences of product recall are the major factors hindering the nasal spray devices market. The various incidences of product recall reported by FDA or companies itself act as a restraining factor for global nasal spray devices market over the forecast period. Nasal drug delivery assessment is regulated by various agencies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA).

The global nasal spray devices market segments include product, prescription, therapeutic, application, and end-user.

Product is sub-segmented into:

  • Decongestion nasal spray
  • Steroid nasal spray
  • Saltwater solution/ saline nasal spray

Prescription is sub-segmented into:

  • Prescribed
  • Over the counter

Therapeutic is sub-segmented into:

  • Antihistamine
  • Nasal steroids
  • Anticholinergic
  • Mast cell inhibitor

Application is sub-segmented into:

  • CNS disorders
  • Nasal congestion
  • Allergic and non-allergic rhinitis
  • Vaccination
  • Other application

End-user is sub-segmented into:

  • ASC/Clinics
  • Home care setting
  • Hospital
  • Pharmacy
  • Other end-user

This report covered the present market conditions and the growth prospects of the global nasal spray devices market for 2019-2027 and considered the revenue generated through the sales of nasal spray devices for the product, prescription, therapeutic, application, and end-user to calculate the market size by considering 2018 as the base year.

Geographically, the global nasal spray devices market has been segmented on the basis of four major regions, which include:

The nasal spray devices market in North America is expected to hold the largest share by 2027 possibilities of increased use of government investments in developing nasal spray products along with the high incidence of asthma and other respiratory diseases. North America constitutes a share of approx. 48% in 2018.

Moreover, a high number of deaths due to air pollution and ongoing clinical trials on nasal spray devices are also expected to boost the growth of nasal spray devices market in North America during the forecast period. The United States nasal spray devices market is significantly driven by government investments to develop nasal spray products along with a high incidence of asthma and other respiratory diseases.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the nasal spray devices market. Asia-Pacific nasal spray devices market will be on up-surging trend owing to the increase in the prevalence of asthma and other respiratory diseases along with the ongoing research and development activities for the development of generic nasal spray products.

The nasal spray devices market is segmented based on prescription which is sub-divided into prescribed and over the counter, on the basis of therapeutic which is sub-divided into anticholinergic, mast cell inhibitor, antihistamine, and nasal steroids, and also segmented on the basis of end user which is sub-divided into home care setting, hospital, ASC/clinics, pharmacy and other end-user.

Adoption of prescribed nasal spray devices in hospitals and clinics helps to administer a prescribed nasal drug delivery by a physician safely. Anticholinergic medications that are adopted in nasal spray devices for the treatment of infections and allergies can be divided as topical anticholinergics and oral anticholinergics. The adoption of nasal steroids relieves symptoms such as mucus production, sinus and nasal congestion, and nasal swelling.

Hospitals adopt different types of nasal spray devices to deliver therapeutic benefits associated with chronic obstructive pulmonary diseases, Alzheimer’s disease, Parkinson disease, etc. Pharmacy market deals with the adoption of nasal spray devices to ensure safe and effective use and delivery of pharmaceutical drugs through the nasal passage.

The major market players of the global nasal spray devices market are:

  • Allergan Inc.
  • Sun Pharmaceuticals Industries, Ltd.
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline

Company profiles covers analysis of important players. Allergan Inc. (Allergan) is an Ireland-based company, headquartered in Dublin. The company has a specialty in the pharmaceuticals with primary focus on developing, manufacturing, marketing and distributing specialty branded, Biosimilar, and Over-The-Counter (OTC) products. GSK manufactures the medication drugs which are used to cure asthma, cancer, infections, fungal disease, diabetes, and mental health.

GlaxoSmithKline (GSK or ‘the company’) is a global healthcare company specialized in the discovery, development, manufacturing, and marketing of pharmaceutical, vaccines and consumer health-related products.

Key Findings of the global nasal spray devices market:

  • Decongestion nasal spray holds the largest market share in terms of product
  • Over-the-counter prescription is anticipated to grow at a significant rate
  • Antihistamine is the fastest growing therapeutics
  • Nasal congestion is the majorly used application of nasal spray devices
  • Home care setting is the fastest growing end-user
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • DECONGESTION NASAL SPRAY HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
      • OVER-THE-COUNTER PRESCRIPTION IS ANTICIPATED TO GROW SIGNIFICANTLY
      • ANTIHISTAMINE IS THE FASTEST GROWING THERAPEUTICS
      • NASAL CONGESTION IS THE MAJORLY USED APPLICATION OF NASAL SPRAY DEVICES
      • HOME CARE SETTING IS THE FASTEST GROWING END-USER
  1. MARKET DETERMINANTS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • SURGE IN INCIDENCE OF RESPIRATORY DISEASES
      • LOW COST OF GENERIC PRESCRIPTION DRUGS
    • MARKET RESTRAINTS
      • STRINGENT REGULATION
      • RISING INCIDENCES OF PRODUCT RECALL
    • MARKET OPPORTUNITIES
      • RISING ADOPTION OF GENERIC DRUGS
      • GROWING DEMAND OF NASAL DRUGS IN PHARMACEUTICAL MARKET
    • MARKET CHALLENGES
      • PATENT EXPIRATION
  1. MARKET BY PRODUCT
    • DECONGESTION NASAL SPRAY
    • SALTWATER SOLUTION/ SALINE NASAL SPRAY
    • STEROID NASAL SPRAY
  2. MARKET BY PRESCRIPTION
    • OVER-THE-COUNTER
    • PRESCRIBED
  3. MARKET BY THERAPEUTIC
    • ANTIHISTAMINE
    • ANTICHOLINERGIC
    • MAST CELL INHIBITOR
    • NASAL STEROIDS
  4. MARKET BY APPLICATION
    • ALLERGIC AND NON-ALLERGIC RHINITIS
    • CNS DISORDERS
    • NASAL CONGESTION
    • VACCINATION
    • OTHER APPLICATION
  5. MARKET BY END-USER
    • ASC/CLINICS
    • HOME CARE SETTING
    • HOSPITAL
    • PHARMACY
    • OTHER END-USER
  6. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
    • SUPPLY CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • PARENT MARKET ANALYSIS
    • OPPORTUNITY MATRIX
  7. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ADAPT PHARMA, INC. (ACQUIRED BY EMERGENT BIOSOLUTIONS)
        • COMPANY OVERVIEW
        • PRODUCT LAUNCH
        • STRATEGIC INITIATIVES
      • ALLERGAN INC.
        • COMPANY OVERVIEW
        • PRODUCT & SERVICES
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • APOTEX
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • BECTON DICKINSON AND COMPANY
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BEXIMCO PHARMACEUTICALS
        • COMPANY OVERVIEW
        • PRODUCT LAUNCH
        • STRATEGIC INITIATIVES
      • CIPLA
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • GLAXOSMITHKLINE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HIKMA PHARMACEUTICALS PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • MERCK & CO., INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MYLAN NV
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • PFIZER, INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SANDOZ INTERNATIONAL GMBH (SUBSIDIARY OF NOVARTIS AG)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • SANOFI-AVENTIS S.A.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SUN PHARMACEUTICALS INDUSTRIES, LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE 1        GLOBAL NASAL SPRAY DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL NASAL SPRAY DEVICES MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 3        GLOBAL DECONGESTION NASAL SPRAY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL SALT WATER SOLUTION/ SALINE NASAL SPRAY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL STEROID NASAL SPRAY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6        GLOBAL NASAL SPRAY DEVICES MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)

TABLE 7        GLOBAL OVER-THE-COUNTER MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL PRESCRIBED MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 9        GLOBAL NASAL SPRAY DEVICES MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)

TABLE 10      GLOBAL ANTIHISTAMINE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11      GLOBAL ANTICHOLINERGIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12      GLOBAL MAST CELL INHIBITOR MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL NASAL STEROIDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14      GLOBAL NASAL SPRAY DEVICES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 15      GLOBAL ALLERGIC AND NON-ALLERGIC RHINITIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL CNS DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17      GLOBAL NASAL CONGESTION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18      GLOBAL VACCINATION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      GLOBAL OTHER APPLICATION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 20      GLOBAL NASAL SPRAY DEVICES MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 21      GLOBAL ASC/CLINICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 22      GLOBAL HOME CARE SETTING MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 23      GLOBAL HOSPITAL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 24      GLOBAL PHARMACY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 25      GLOBAL OTHER END-USER MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 26      GLOBAL NASAL SPRAY DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 27      NORTH AMERICA NASAL SPRAY DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 28      EUROPE NASAL SPRAY DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 29      ASIA PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 30      REST OF WORLD NASAL SPRAY DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1      GLOBAL NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 2      DEATHS CAUSED DUE TO VARIOUS RESPIRATORY DISEASES 2012-2016

FIGURE 3      GLOBAL NASAL SPRAY DEVICES MARKET SHARE BY PRODUCT 2018 & 2027 (%)

FIGURE 4      GLOBAL NASAL SPRAY DEVICES MARKET BY DECONGESTION NASAL SPRAY 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL NASAL SPRAY DEVICES MARKET BY SALT WATER SOLUTION/ SALINE NASAL SPRAY 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL NASAL SPRAY DEVICES MARKET BY STEROID NASAL SPRAY 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL NASAL SPRAY DEVICES MARKET SHARE BY PRESCRIPTION 2018 & 2027 (%)

FIGURE 8      GLOBAL NASAL SPRAY DEVICES MARKET BY OVER-THE-COUNTER 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL NASAL SPRAY DEVICES MARKET BY PRESCRIBED 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL NASAL SPRAY DEVICES MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)

FIGURE 11   GLOBAL NASAL SPRAY DEVICES MARKET BY ANTIHISTAMINE 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL NASAL SPRAY DEVICES MARKET BY ANTICHOLINERGIC 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL NASAL SPRAY DEVICES MARKET BY MAST CELL INHIBITOR 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL NASAL SPRAY DEVICES MARKET BY NASAL STEROIDS 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL NASAL SPRAY DEVICES MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 16   GLOBAL NASAL SPRAY DEVICES MARKET BY ALLERGIC AND NON-ALLERGIC RHINITIS 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL NASAL SPRAY DEVICES MARKET BY CNS DISORDERS 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL NASAL SPRAY DEVICES MARKET BY NASAL CONGESTION 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL NASAL SPRAY DEVICES MARKET BY VACCINATION 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL NASAL SPRAY DEVICES MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL NASAL SPRAY DEVICES MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE 22   GLOBAL NASAL SPRAY DEVICES MARKET BY ASC/CLINICS 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL NASAL SPRAY DEVICES MARKET BY HOME CARE SETTING 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL NASAL SPRAY DEVICES MARKET BY HOSPITAL 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL NASAL SPRAY DEVICES MARKET BY PHARMACY 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL NASAL SPRAY DEVICES MARKET BY OTHER END-USER 2019-2027 ($ MILLION)

FIGURE 27   PORTER’S FIVE FORCE MODEL

FIGURE 28   KEY BUYING CRITERIA

FIGURE 29   GLOBAL NASAL SPRAY DEVICES SUPPLY CHAIN ANALYSIS

FIGURE 30   GLOBAL NASAL SPRAY DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 31   THE UNITED STATES NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 32   CANADA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 33   THE UNITED KINGDOM NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 34   FRANCE NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 35   GERMANY NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 36   SPAIN NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 37   ITALY NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 38   REST OF EUROPE NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 39   CHINA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 40   INDIA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 41   JAPAN ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 42   AUSTRALIA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 43   SOUTH KOREA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 44   REST OF ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 45   LATIN AMERICA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 46   MIDDLE EAST AND AFRICA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 47   NASAL SPRAY DEVICES COMPANY MARKET SHARE 2017 (%)

  1. MARKET BY PRODUCT
    • DECONGESTION NASAL SPRAY
    • SALTWATER SOLUTION/ SALINE NASAL SPRAY
    • STEROID NASAL SPRAY
  2. MARKET BY PRESCRIPTION
    • OVER-THE-COUNTER
    • PRESCRIBED
  3. MARKET BY THERAPEUTIC
    • ANTIHISTAMINE
    • ANTICHOLINERGIC
    • MAST CELL INHIBITOR
    • NASAL STEROIDS
  4. MARKET BY APPLICATION
    • ALLERGIC AND NON-ALLERGIC RHINITIS
    • CNS DISORDERS
    • NASAL CONGESTION
    • VACCINATION
    • OTHER APPLICATION
  5. MARKET BY END-USER
    • ASC/CLINICS
    • HOME CARE SETTING
    • HOSPITAL
    • PHARMACY
    • OTHER END-USER
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now